147 related articles for article (PubMed ID: 24576475)
1. Silent reintroduction of wild-type poliovirus to Israel, 2013 - risk communication challenges in an argumentative atmosphere.
Kaliner E; Moran-Gilad J; Grotto I; Somekh E; Kopel E; Gdalevich M; Shimron E; Amikam Y; Leventhal A; Lev B; Gamzu R
Euro Surveill; 2014 Feb; 19(7):20703. PubMed ID: 24576475
[TBL] [Abstract][Full Text] [Related]
2. Insidious reintroduction of wild poliovirus into Israel, 2013.
Anis E; Kopel E; Singer SR; Kaliner E; Moerman L; Moran-Gilad J; Sofer D; Manor Y; Shulman LM; Mendelson E; Gdalevich M; Lev B; Gamzu R; Grotto I
Euro Surveill; 2013 Sep; 18(38):. PubMed ID: 24084337
[TBL] [Abstract][Full Text] [Related]
3. Public health response to the silent reintroduction of wild poliovirus to Israel, 2013-2014.
Moran-Gilad J; Kaliner E; Gdalevich M; Grotto I
Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S140-S145. PubMed ID: 28034372
[TBL] [Abstract][Full Text] [Related]
4. Comparing Israeli and Palestinian polio vaccination policies and the challenges of silent entry of wild poliovirus in 2013-14: a 'natural experiment'.
Flahault A; Orenstein W; Garon J; Kew O; Bickford J; Tulchinsky T
Int J Public Health; 2015 Nov; 60(7):765-6. PubMed ID: 26140857
[No Abstract] [Full Text] [Related]
5. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
Chowdhary R; Dhole TN
J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
[TBL] [Abstract][Full Text] [Related]
6. Prosocial polio vaccination in Israel.
Wells CR; Huppert A; Fitzpatrick MC; Pandey A; Velan B; Singer BH; Bauch CT; Galvani AP
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13138-13144. PubMed ID: 32457142
[TBL] [Abstract][Full Text] [Related]
7. Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel.
Yaari R; Kaliner E; Grotto I; Katriel G; Moran-Gilad J; Sofer D; Mendelson E; Miller E; Huppert A; ; Anis E; Kopel E; Manor Y; Mor O; Shulman L; Singer R; Weil M
BMC Med; 2016 Jun; 14(1):95. PubMed ID: 27334457
[TBL] [Abstract][Full Text] [Related]
8. Laboratory challenges in response to silent introduction and sustained transmission of wild poliovirus type 1 in Israel during 2013.
Shulman LM; Mendelson E; Anis E; Bassal R; Gdalevich M; Hindiyeh M; Kaliner E; Kopel E; Manor Y; Moran-Gilad J; Ram D; Sofer D; Somekh E; Tasher D; Weil M; Gamzu R; Grotto I
J Infect Dis; 2014 Nov; 210 Suppl 1():S304-14. PubMed ID: 25316849
[TBL] [Abstract][Full Text] [Related]
9. How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience.
Tasher D; Rahav G; Levine H; Sofer D; Linder N; Anis E; Shohat T; Manor Y; Kopel E; Shulman LM; Mendelson E; Shalit I; Somekh E
Vaccine; 2016 Jan; 34(3):299-301. PubMed ID: 26679402
[No Abstract] [Full Text] [Related]
10. Molecular Characterization of Polio from Environmental Samples: ISSP, The Israeli Sewage Surveillance Protocol.
Shulman LM; Manor Y; Hindiyeh M; Sofer D; Mendelson E
Methods Mol Biol; 2016; 1387():55-107. PubMed ID: 26983731
[TBL] [Abstract][Full Text] [Related]
11. Intensified environmental surveillance supporting the response to wild poliovirus type 1 silent circulation in Israel, 2013.
Manor Y; Shulman LM; Kaliner E; Hindiyeh M; Ram D; Sofer D; Moran-Gilad J; Lev B; Grotto I; Gamzu R; Mendelson E
Euro Surveill; 2014 Feb; 19(7):20708. PubMed ID: 24576473
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013.
Shulman LM; Gavrilin E; Jorba J; Martin J; Burns CC; Manor Y; Moran-Gilad J; Sofer D; Hindiyeh MY; Gamzu R; Mendelson E; Grotto I;
Euro Surveill; 2014 Feb; 19(7):20709. PubMed ID: 24576471
[TBL] [Abstract][Full Text] [Related]
13. [End phase challenges of poliomyelitis eradication programme realization].
Jarzabek Z
Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
[TBL] [Abstract][Full Text] [Related]
14. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
[TBL] [Abstract][Full Text] [Related]
15. 2005 poliovirus eradication: poliovirus presence in Cyprus 2 years after.
Richter J; Bashiardes S; Koptides D; Tryfonos C; Pissarides N; Stavrou N; Papageorgiou GT; Christodoulou C
Water Sci Technol; 2008; 58(3):647-51. PubMed ID: 18725734
[TBL] [Abstract][Full Text] [Related]
16. Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(25):846-50. PubMed ID: 21716199
[TBL] [Abstract][Full Text] [Related]
17. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
18. Environmental Isolation of Circulating Vaccine-Derived Poliovirus After Interruption of Wild Poliovirus Transmission - Nigeria, 2016.
Etsano A; Damisa E; Shuaib F; Nganda GW; Enemaku O; Usman S; Adeniji A; Jorba J; Iber J; Ohuabunwo C; Nnadi C; Wiesen E
MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(30):770-3. PubMed ID: 27490081
[TBL] [Abstract][Full Text] [Related]
19. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
Orenstein WA;
Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
[TBL] [Abstract][Full Text] [Related]
20. Lessons from a public health emergency--importation of wild poliovirus to Israel.
Kopel E; Kaliner E; Grotto I
N Engl J Med; 2014 Sep; 371(11):981-3. PubMed ID: 25207764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
